Protein C activated - KM Biologics/Teijin
Alternative Names: Activated protein C - Kaketsuken/Teijin; Anact C; CTC-111Latest Information Update: 19 Nov 2021
Price :
$50 *
At a glance
- Originator Kaketsuken; Teijin Pharma
- Developer Teijin Pharma
- Class Anticoagulants; Antithrombotics; Biological factors; Blood proteins; Enzyme precursors; Glycoproteins
- Mechanism of Action Protein C stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Deep vein thrombosis; Disseminated intravascular coagulation; Pulmonary embolism
Most Recent Events
- 31 Jul 2001 Launched for Pulmonary embolism in Japan (IV)
- 31 Jul 2001 Launched for Disseminated intravascular coagulation in Japan (IV)
- 31 Jul 2001 Launched for Thrombosis in Japan (IV)